Sat, Feb 22, 2025
[Archive]
Volume 10, Issue 1 (Feb 2025)
JNFS 2025, 10(1): 178-193 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Salimi Z, Asadi M, Mansoori A. The Effect of Whey Protein Consumption on Postprandial Glucose, Insulin and Incretin Responses in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Acute-Term Controlled Clinical Trials. JNFS 2025; 10 (1) :178-193
URL: http://jnfs.ssu.ac.ir/article-1-936-en.html
URL: http://jnfs.ssu.ac.ir/article-1-936-en.html
Department of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Abstract: (867 Views)
Background: Postprandial hyperglycemia is an important factor which contributes to glycemic status and complications of diabetes mellitus. This was a systematic review and meta-analysis that was conducted to evaluate the overall effect of whey protein consumption on postprandial glucose, insulin, and incretin hormone responses in patients with type 2 diabetes mellitus (T2DM). Methods: Web of Science, Cochrane Library, EMBASE, PubMed, and Scopus databases were searched to find acute-term controlled clinical trials investigating the effect of all types of whey proteins on products postprandial glucose (PPG) response as the main outcome and also insulin and incretin responses as secondary outcomes in patients with T2DM. Ten trials met the eligibility criteria. A random-effects model was used to obtain pooled effect size. Results: The pooled analysis of the included trials indicated a significant reduction in the mean of glucose in the area under the curve [standard mean difference (SMD)=-1.295, 95% CI: -1.878 to -0.712, P<0.001] and also an increase in the mean of insulin, gastric inhibitory polypeptide (GIP) and glucagon‐like peptide‐1 (SMD=0.562, 95% CI: 0.303 to 0.822, P<0.001, SMD=0.349, 95% CI: 0.074 to 0.624, P=0.013 and SMD=0.439, 95% CI: 0.154 to 0.724, P=0.003, respectively) in participants who consumed whey protein compared with the control group. Conclusion: According to the findings, whey protein intake is effective in reducing postprandial blood glucose as well as increasing postprandial insulin and incretin levels. Thus, whey protein can be considered a strategy to improve glycemic control in patients with T2DM.
Type of article: review article |
Subject:
public specific
Received: 2023/07/23 | Published: 2025/02/4 | ePublished: 2025/02/4
Received: 2023/07/23 | Published: 2025/02/4 | ePublished: 2025/02/4
References
1. Akhavan T, Luhovyy BL, Brown PH, Cho CE & Anderson GH 2010. Effect of premeal consumption of whey protein and its hydrolysate on food intake and postmeal glycemia and insulin responses in young adults–. The American journal of clinical nutrition. 91 (4): 966-975.
2. Akhavan T, et al. 2014. Mechanism of action of pre-meal consumption of whey protein on glycemic control in young adults. The Journal of nutritional biochemistry. 25 (1): 36-43.
3. Almario RU, Buchan WM, Rocke DM & Karakas SE 2017. Glucose-lowering effect of whey protein depends upon clinical characteristics of patients with type 2 diabetes. BMJ Open diabetes research and care. 5 (1): e000420.
4. Ang M, Müller AS, Wagenlehner F, Pilatz A & Linn T 2012. Combining protein and carbohydrate increases postprandial insulin levels but does not improve glucose response in patients with type 2 diabetes. Metabolism. 61 (12): 1696-1702.
5. Aune D, Norat T, Romundstad P & Vatten LJ 2013. Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. The American journal of clinical nutrition. 98 (4): 1066-1083.
6. Bjørnshave A, Hermansen K & Holst JJ 2018. Pre-meal effect of whey proteins on metabolic parameters in subjects with and without type 2 diabetes: a randomized, crossover trial. Nutrients. 10 (2): 122.
7. Bosscher D, et al. 2009. Dairy peptides in effective blood glucose management. Australian journal of dairy technology. 64 (1): 54.
8. Brekke H, Sunesson Å, Axelsen M & Lenner R 2004. Attitudes and barriers to dietary advice aimed at reducing risk of type 2 diabetes in first‐degree relatives of patients with type 2 diabetes. Journal of human nutrition and dietetics. 17 (6): 513-521.
9. Brouns F, et al. 2005. Glycaemic index methodology. Nutrition research reviews. 18 (1): 145-171.
10. Ceriello A, Colagiuri S, Gerich J & Tuomilehto J 2008. Guideline for management of postmeal glucose. Nutrition, metabolism and cardiovascular diseases. 18 (4): S17-S33.
11. Da Silva MS, et al. 2014. Associations between dairy intake and metabolic risk parameters in a healthy French-Canadian population. Applied physiology, nutrition, and metabolism. 39 (12): 1323-1331.
12. Daly RM, et al. 2014. The effects of progressive resistance training combined with a whey-protein drink and vitamin D supplementation on glycaemic control, body composition and cardiometabolic risk factors in older adults with type 2 diabetes: study protocol for a randomized controlled trial. Trials. 15 (1): 431.
13. DeFronzo RA 2009. From the triumvirate to the „ominous octet”: a new paradigm for the treatment of type 2 diabetes mellitus. Clinical diabetology. 10 (3): 101-128.
14. Díaz-López A, et al. 2016. Dairy product consumption and risk of type 2 diabetes in an elderly Spanish Mediterranean population at high cardiovascular risk. European journal of nutrition. 55 (1): 349-360.
15. Drehmer M, et al. 2015. Associations of dairy intake with glycemia and insulinemia, independent of obesity, in Brazilian adults: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). The American journal of clinical nutrition. 101 (4): 775-782.
16. Egger M, Smith GD, Schneider M & Minder C 1997. Bias in meta-analysis detected by a simple, graphical test. Bmj. 315 (7109): 629-634.
17. Flaim C, Kob M, Di Pierro AM, Herrmann M & Lucchin L 2017. Effects of a whey protein supplementation on oxidative stress, body composition and glucose metabolism among overweight people affected by diabetes mellitus or impaired fasting glucose: A pilot study. The Journal of nutritional biochemistry. 50: 95-102.
18. Floyd J, Fajans SS, Conn JW, Knopf RF & Rull J 1966. Stimulation of insulin secretion by amino acids. The Journal of clinical investigation. 45 (9): 1487-1502.
19. Frid AH, Nilsson M, Holst JJ & Björck IM 2005. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects–. American journal of clinical nutrition. 82 (1): 69-75.
20. Gaffney KA, et al. 2018. Nil Whey Protein Effect on Glycemic Control after Intense Mixed-Mode Training in Type 2 Diabetes. Medicine and science in sports and exercise. 50 (1): 11-17.
21. Goudarzi M & Madadlou A 2013. Influence of whey protein and its hydrolysate on prehypertension and postprandial hyperglycaemia in adult men. International dairy journal. 33 (1): 62-66.
22. Hall W, Millward D, Long S & Morgan L 2003. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. British journal of nutrition. 89 (2): 239-248.
23. Higgins J & Green S 2011. Handbook for systematic reviews of interventions version 5.1. 0 [updated March 2011]. The Cochrane Collaboration.
24. Jakubowicz D, et al. 2013. Effect of whey protein concentrate on blood glucose, insulin and C-peptide serum levels following a high glycaemic index breakfast in patients with type 2 diabetes. In Diabetologia.
25. Jakubowicz D & Froy O 2013. Biochemical and metabolic mechanisms by which dietary whey protein may combat obesity and Type 2 diabetes. The Journal of nutritional biochemistry. 24 (1): 1-5.
26. Jakubowicz D, et al. 2014. Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial. Diabetologia. 57 (9): 1807-1811.
27. Jakubowicz D, Landau Z, Wainstein J, Bar-Dayan Y & Froy O 2016. Whey Protein Induces Greater Reduction of Postprandial Glycemia and HbA1c. Weight Loss and Satiety Compared to Other Protein Sources in Type. 2.
28. Jakubowicz D, et al. 2017. High-energy breakfast based on whey protein reduces body weight, postprandial glycemia and HbA1C in Type 2 diabetes. Journal of nutritional biochemistry. 49: 1-7.
29. King DG, et al. 2018. A small dose of whey protein co-ingested with mixed-macronutrient breakfast and lunch meals improves postprandial glycemia and suppresses appetite in men with type 2 diabetes: a randomized controlled trial. The American journal of clinical nutrition. 107 (4): 550-557.
30. Lau J, Ioannidis JP & Schmid CH 1997. Quantitative synthesis in systematic reviews. Annals of internal medicine. 127 (9): 820-826.
31. Lovegrove JA & Givens DI 2016. Dairy food products: good or bad for cardiometabolic disease? Nutrition research reviews. 29 (2): 249-267.
32. Marathe CS, Rayner CK, Jones KL & Horowitz M 2013. Relationships between gastric emptying, postprandial glycemia, and incretin hormones. Diabetes care. 36 (5): 1396-1405.
33. Mignone L, et al. 2016. A whey/guar" preload" improves postprandial glycaemia and HbA (1c) in type 2 diabetes: a 12-week, single-blind, randomised and placebo controlled trial. Diabetologia. 59 (Suppl. 1): S9-S9.
34. Mignone LE, Wu T, Horowitz M & Rayner CK 2015. Whey protein: The “whey” forward for treatment of type 2 diabetes? World journal of diabetes. 6 (14): 1274.
35. Moher D, Liberati A, Tetzlaff J & Altman DG 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine. 151 (4): 264-269.
36. Morgan LM, Shi J-W, Hampton SM & Frost G 2012. Effect of meal timing and glycaemic index on glucose control and insulin secretion in healthy volunteers. British journal of nutrition. 108 (7): 1286-1291.
37. Mortensen L, et al. 2012. Effects of different fractions of whey protein on postprandial lipid and hormone responses in type 2 diabetes. European journal of clinical nutrition. 66 (7): 799.
38. Mortensen LS, et al. 2009. Differential effects of protein quality on postprandial lipemia in response to a fat-rich meal in type 2 diabetes: comparison of whey, casein, gluten, and cod protein–. The American journal of clinical nutrition. 90 (1): 41-48.
39. Pal S & Radavelli‐Bagatini S 2013. The effects of whey protein on cardiometabolic risk factors. Obesity reviews. 14 (4): 324-343.
40. Plat L, et al. 1996. Effects of morning cortisol elevation on insulin secretion and glucose regulation in humans. American journal of physiology-endocrinology and metabolism. 270 (1): E36-E42.
41. Power-Grant O, et al. 2015. In vitro bioactive properties of intact and enzymatically hydrolysed whey protein: targeting the enteroinsular axis. Food & function. 6 (3): 972-980.
42. Raben A 2014. Glycemic index and metabolic risks: how strong is the evidence? Oxford University Press.
43. Rizza RA 2010. Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy. Diabetes. 59 (11): 2697-2707.
44. Smedegaard SB, et al. 2021. β-Lactoglobulin Elevates Insulin and Glucagon Concentrations Compared with Whey Protein—A Randomized Double-Blinded Crossover Trial in Patients with Type Two Diabetes Mellitus. Nutrients. 13 (2): 308.
45. Standl E, Schnell O & Ceriello A 2011. Postprandial hyperglycemia and glycemic variability: should we care? Diabetes care. 34 (Supplement 2): S120-S127.
46. Tessari P, et al. 2007. Slow versus fast proteins in the stimulation of beta‐cell response and the activation of the entero‐insular axis in type 2 diabetes. Diabetes/metabolism research and reviews. 23 (5): 378-385.
47. Watson LE, et al. 2019. A whey/guar "preload" improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: A 12-week, single-blind, randomized, placebo-controlled trial. Diabetes, obesity and metabolism. 21 (4): 930-938.
48. Woerle HJ, et al. 2007. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes: importance of postprandial glycemia to achieve target HbA1c levels. Diabetes research and clinical practice. 77 (2): 280-285.
49. Wu T, et al. 2016. A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetes. Diabetes care. 39 (4): 511-517.
50. Zhang J, et al. 2016. Effect of whey protein on blood lipid profiles: a meta-analysis of randomized controlled trials. European journal of clinical nutrition. 70 (8): 879.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
